- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Marksans Pharma Limited — Updates, 12-08-2026: Press Release
12-08-2026 | 12:34 pm
12-08-2026 | 12:34 pm
Marksans Pharma delivered record quarterly profitability with PAT up 174% to ₹159 Cr and EBITDA rising 113% to ₹213 Cr. Cash crossed ₹1,000 Cr. UK & Europe revenue hit a high of ₹356 Cr, with acquisitions QliniQ and ABCnow bolstering European expansion.
No comments yet. Be the first to comment!